Auro Laboratories Ltd

NSE: AUROLAB · BSE: 530233 · Pharmaceuticals & Biotechnology · 15 announcements

Auro Laboratories Ltd news stories on ALFA NewsRead the news →

Share price: ₹232.50
Market cap: ₹144.9 Cr
Revenue (annual): ₹32.61 Cr
Net profit (annual): ₹3.53 Cr
P/E (TTM): 30.9×Sector 47.4×
Promoter holding: 52.40%+0.22% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Regulatory Approval 2 Other Announcement 2 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Credit Rating 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Jun 2026 18:53 IST BSE

Management Change

Auro Laboratories Management Change

Auro Laboratories re-appointed Mr. Kiran Suresh Kulkarni as Whole Time Director. The three-year term starts May 24, 2027, subject to shareholder approval.

Execution: 3 years

Read the filing ↗

28 May 2026 20:01 IST BSE

Management Change

Auro Laboratories Management Change

Mr. Kuntal Pancholi resigned as Chief Financial Officer and Key Managerial Personnel of Auro Laboratories effective May 28, 2026. He cited personal reasons for his departure.

Read the filing ↗